GLYCOPROTEIN MARKET REPORT OVERVIEW
-
Request a Free sample to learn more about this report
The global glycoprotein market size was USD 491.1 million in 2022 and is projected to touch USD 657.74 million by 2031, exhibiting a CAGR of 3.3% during the forecast period.
Glycoprotein is a class of proteins. It belongs to carbohydrate groups and attached to polypeptide chain. The molecule that consists of protein plus carbohydrate. It plays an essential role in the body. For instance, in the immune system key molecules are commonly glycoproteins. It helps in building immunity. The molecule has oligosaccharide chains. The protein is found outside of the plasma membrane.
Growing use of the protein molecule in the healthcare industry is estimated to fuel market growth. It has an excellent adhesive characteristic which is projected to drive market growth. Increasing demand for immunological activities which is predicted to increase market growth. Increasing R&D activities in the healthcare sector is estimated to stimulate market growth. Growing heterogeneity of glycan structure is expected to boost product adoption during the forecast period. Increasing technological advancements in healthcare and food sector is anticipated to incite market growth. Rising drug therapies and new product launches is predicted to boost product adoption.
COVID 19 Impact: Law of Raw Materials Due to Lockdown to Hamper Market Growth
COVID-19 pandemic impacted economic level of the market. Lockdown restriction led to scarcity of raw materials. Lack of potential manpower halted production activity. The market witnessed drop in sales due to lockdown restriction. Pandemic impacted supply chain operations and caused minor stumbling locks. Shut down of manufacturing units hampered product demand.
On the contrary, increasing demand for research and innovation in the healthcare sector boosted market growth. High demand for healthcare industry during pandemic propel market growth. Increasing need for treatments and growing demand for vaccines are anticipated to boost market growth.
LATEST TRENDS
"Growth in Healthcare Sector to Propel Market Growth"
Increasing demand from healthcare sector is expected to fuel market growth. Growing prevalence of breast cancer globally is estimated to boost molecule adoption. Increasing demand to boost metabolism in the body is predicted to surge market growth. Increasing heterogeneity of glycan structure is projected to drive market growth during the forecast period. Growing need for blood grouping in human body is estimated to accelerate market growth. Increasing demand for stabilizing and protecting a few proteins is projected to drive market growth. Rising need to perform proteins function in the body is anticipated to boost glycoprotein market growth. Growing demand for immunity boosting systems in the hospital sector is estimated to boost product adoption.
GLYCOPROTEIN MARKET SEGMENTATION
-
Request a Free sample to learn more about this report
- By Type
On the basis of type, the market is classified into n-linkage, o-linkage, and others.
N-linkage is expected to be leading part of segmentation type.
- By Application
Based on application, the market is classified into hospital, research institutes, and others.
Hospital is estimated to be leading part of the application segment.
DRIVING FACTORS
"Growing Demand to Protect Epithelial Cells to Foster Market Growth "
Increasing demand for protecting epithelial cells in human body is estimated to boost market growth. Increasing demand for healthy skin is projected to drive market growth. Glycoproteins are found on the surface of skin cell known as epithelial cell. The molecule attach to human skin cell to each other. Such form of creating barrier to protect our body is estimated to surge market growth. Increasing need to secrete mucus in body is projected to boost molecule adoption. Mucus helps to protect stomach lining from harsh acids. Such benefits help human to be healthy and which is estimated to boost market growth. Growing need to keep lungs airways clean is estimated to increase glycoprotein market growth.
"Increasing Demand for Immunology to Incite Market Growth "
Increasing need to circulate blood vessel lining through glycoprotein is estimated to fuel market growth. Growing need to roll blood cells along with blood vessel is projected to drive market growth. Growing need to travel white blood cell all over the body is estimated to increase market growth. Further, the protein is also important for red blood cells. Increasing demand for red blood cell in the body is estimated to stimulate glycoprotein market growth. Increasing need to stimulate coagulation of blood is anticipated to increase market growth during the forecast period. Rising need to protect cell lining from body cavity is predicted to boost protein adoption.
RESTRAINING FACTORS
"Lack of Research and Clinical Experts to Hamper Market Growth"
Lack of research and clinical expertise in healthcare sector is estimated to reduce market growth. Presence of other biological projects is estimated to hamper market growth during the forecast period.
GLYCOPROTEIN MARKET REGIONAL INSIGHTS
-
Request a Free sample to learn more about this report
"Increasing Pharmaceutical and Medical Research Activities in North America to Drive Market Share "
North America is estimated to hold glycoprotein market share due to increasing pharmaceutical and medical research activities. Increasing investment by major market players for the development of hospitals equipment. Rising government initiatives for disease diagnosis therapy is estimated to fuel market growth. Increasing demand from healthy diet and better metabolism among the population is estimated to increase market growth.
Europe is estimated to show considerable market growth due to increasing number of advanced research in healthcare sector. Rising government initiatives for healthcare sector to support numerous start-ups and leading companies. Such anticipated to boost market growth.
Asia Pacific is expected to show significant market growth due to growing progress in pharmaceuticals. Growth in research institutes and hospitals in the region is estimated to increase market growth. Increasing demand for improving R&D and healthcare is projected to drive market growth during the forecast period.
Middle East and Africa is estimated to show considerable market growth due to increasing demand for protein industry. Growing investment in medical and pharmaceuticals is projected to drive market growth during the forecast period.
KEY INDUSTRY PLAYERS
"Leading Players Adopt New Launch Strategies to Stay Competitive"
The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.
List of Market Players Profiled
- Sigma (U.S.)
- Creative Diagnostics (U.S.)
- R&D Systems (U.S.)
- Enzo Life Sciences (U.S.)
- Thermo Fisher Scientific (U.S.)
- Epitope Diagnostics (U.S.)
- BD Biosciences (India)
REPORT COVERAGE
This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 491.1 Million in 2022 |
Market Size Value By |
US$ 657.74 Million by 2031 |
Growth Rate |
CAGR of 3.3% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type, Application & Region |
Frequently Asked Questions
-
What value is the glycoprotein market expected to touch by 2031?
The global glycoprotein market size was USD 491.1 million in 2022 and is projected to touch USD 657.74 million by 2031.
-
What CAGR is the glycoprotein market expected to exhibit by 2031?
The glycoprotein market is expected to exhibit a CAGR of 3.3 % by 2031.
-
Which are the driving factors of the glycoprotein market?
Drivers of this glycoprotein market are growing demand to protect epithelial cells and increasing demand for immunology.
-
Which are the top companies operating in the glycoprotein market?
Sigma, Creative Diagnostics, R&D Systems, Enzo Life Sciences, Thermo Fisher Scientific, Epitope Diagnostic, and BD Biosciences are the top companies operating in the glycoprotein market